S&P DJI Announces September 2026 Quarterly Rebalance
Filed with ASX · · 6 pages · English
In the deck
Story so far
Earlier from Dimerix
- Dimerix secures a$34 million non-dilutive facility to fund key clinical milestones
- Dimerix Secures A$34 Million Non-Dilutive Funding Facility
- Trading Halt
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
Later from Dimerix
- Dimerix Investor Presentation
- Dimerix DMX-652 Granted Mexican Composition of Matter Patent
- Dimerix Presents at E&P Healthcare Conference 2026
- Waiver of Listing Rule 10.1 Granted
- Dimerix Presents at ASX SMIDcaps Conference 2026
Follow Dimerix into a list and get an email when it puts out news.
Follow Dimerix